2
0
The cholera outbreak in South Sudan, which the government declared in October 2024, continues to worsen. Around 21 000 suspected and confirmed cases and around 367 deaths have been reported so far as of 15 January 2025, with more than a quarter of these reported in the last week of December. The case fatality ratio is currently 1.8%, which exceeds World Health Organization (WHO)’s target threshold of less than 1%.
While cholera cases have been reported in 31 out of 80 counties across seven states and one administrative area, Rubkona county accounts for 47% of total cases, followed by Juba county at around 10%. The ongoing influx of refugees and returnees fleeing the conflict in Sudan increases the risk of infectious disease outbreaks like cholera and continues to exert pressure on an already fragile health system. Renk county, the primary entry point for most of the returnees and refugees from Sudan, has reported around 550 confirmed and suspected cholera cases and three deaths. This accounts for almost 4% of the total cholera cases reported nationwide.
To address the rising cases of cholera, the Ministry of Health, with support from WHO and partners , in January 2025 rolled out several oral cholera vaccination campaigns in four high-risk counties – Malakal, Juba, Renk and, Rubkona. With support from Gavi, the Vaccine Alliance, around 4 million doses of the vaccine have been approved and around 910 000 doses have so far been administered in the four counties, above 90% coverage.
“We extend our heartfelt gratitude to our healthcare workers on the frontlines, who are dedicated to caring for cholera patients and curbing the transmission,” says Minister of Health, Hon Yolanda Awel Deng. “The vaccine is lifesaving, and I encourage the community to get vaccinated and adhere to all precautionary measures to minimize the risk of contracting cholera.”
WHO continues to distribute essential medical supplies for cholera response to local and national health authorities and partners. These include investigation and treatment kits, cholera beds, standalone rapid diagnostic tests and personal protective equipment to enhance cholera preparedness and response efforts. The supplies can treat 4700 cholera cases.
“While oral cholera vaccination is important, it is one of several tools to curb the ongoing outbreak,” says Dr Humphrey Karamagi, WHO Representative in South Sudan, “WHO is supporting health authorities in all aspects of the outbreak response to ensure that we address comprehensive health needs and bring this outbreak to an end.”
WHO has facilitated the establishment of a 50-bed cholera treatment centre at Juba Teaching Hospital and is supporting the deployment of nine rapid response teams from national level to 11 priority counties to support implementing partners on the ground provide critical case management.
Gai and her family have since fully recovered and have been vaccinated. “I sincerely thank all the health workers and authorities for their care,” she says. “The support has been invaluable during this difficult time for my family, and we are grateful. Now we have been vaccinated and no longer worried.”
World Health Organization (WHO) – South Sudan.
About Author
OTHER ARTICLES
Zambia : The vital role of community health assistants in public health surveillance
Lusaka — African health ministers and partners are calling for increased investment in integrated health services to address the growing burden of severe noncommunicable diseases (NCDs), particularly those affecting women and underserved populations across the region. At a high-level side event during the Seventy-fifth session of the WHO Regional Committee for Africa, delegates emphasized the urgent need for equitable access to prevention, screening, treatment, and rehabilitation across the continuum of care for NCDs. Disparities are especially pronounced in rural areas, where health infrastructure and services remain inadequate. Breast and cervical cancers are among the leading causes of cancer-related deaths among women in sub-Saharan Africa—particularly cervical cancer, which is both preventable and treatable. It remains the most common cause of cancer death for women in the region. In 2022, Africa accounted for nearly a quarter (23%) of the 76 000 global cervical cancer deaths. Meanwhile, severe NCDs such as Type 1 diabetes, sickle cell disease, and heart conditions claim more than half a million lives annually, including among children, adolescents, and young adults in some of the continent’s poorest communities. Inequitable access to health services continues to hinder efforts to reduce this burden. To improve cervical and breast cancer care in the region, urgent investment is needed in leadership, governance, and financing. Strengthening these foundations is critical in the current funding landscape. Advancements in strategic planning, healthcare infrastructure, workforce training, and—most importantly—equitable access to screening, diagnostic, and treatment services are essential. To address these challenges, WHO and its partners showcased successful integrated models such as the Women’s Integrated Care for Cancer Services (WICS), the BEAT Breast Cancer Project, and the PEN-Plus Strategy. WICS strengthens early detection, treatment, and integration of women’s cancer services into primary health care systems in Côte d’Ivoire, Kenya, and Zimbabwe. The BEAT Breast Cancer Project is a transformative multi-year initiative aimed at reducing breast cancer mortality among women in Tanzania and Ghana through early detection, timely diagnosis, and comprehensive treatment access. “PEN-Plus, WICS and the BEAT Breast Cancer Initiative are models for a new standard of care, rooted in equity, access and health justice. I urge countries to prioritize policies that embed these models into broader health system strengthening, said Dr Mohamed Janabi, WHO Regional Director for Africa”. Côte d’Ivoire offers a compelling example of progress, combining high HPV vaccination coverage—reaching over three million girls (91.4%)—with WICS-supported community-based screening campaigns to strengthen cervical cancer prevention. In Kenya, cervical cancer screening has been successfully integrated into national health services. “This gathering marks a pivotal moment to accelerate action for breast cancer prevention in Africa. We deeply value the leadership of the Ministries of Health of Ghana and Tanzania, and the steadfast support of the Pfizer Foundation in helping us achieve this milestone. The side event builds momentum for the policy prioritization of women’s cancers, partnerships to strengthen the broader women’s cancer ecosystem, and advance a health-systems approach to breast cancer prevention and management”, said Dr Somesh Kumar, Senior Director, Jhpiego. PEN-Plus expands access to care for severe NCDs at the district hospital level. Since its implementation, 20 countries in Africa have increased access to services for severe NCDs. Over 15 000 people are currently receiving treatment for chronic conditions such as sickle cell disease and Type 1 diabetes through PEN-Plus clinics.
Confirmed Case of Mpox in Senegal: Situation Update (as of August 27, 2025)